COMMUNIQUÉS West-GlobeNewswire

Voting Rights and Shares Capital of the Company
11/06/2024
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, June 11, 2024 (GLOBE NEWSWIRE [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
11/06/2024
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 11 juin 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance
11/06/2024
35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases, sexually transmitted and urine tract infections // QIAcuity [...]
PetMeds® Announces Its Fourth Quarter and Fiscal Year End Financial Results
11/06/2024
DELRAY BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended [...]
Neurona Therapeutics Appoints Dr. Manher Joshi as Chief Medical Officer
11/06/2024
SAN FRANCISCO, June 11, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the [...]
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
11/06/2024
BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
11/06/2024
BOSTON, June 11, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]
Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
11/06/2024
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage [...]
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
11/06/2024
Company Announcement COPENHAGEN, Denmark; June 11, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document [...]
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
11/06/2024
CLEVELAND, June 11, 2024 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a leader in the use of peripheral nerve stimulation (PNS) to address different types of pain throughout the body, announced the publication of a review of [...]
Origin Life Sciences Abstract Accepted for Presentation at 2024 Military Health System Research Symposium (MHSRS) Discussing Innovative Technologies and Devices for Treatment of Battlefield Wounds in Prolonged Care to Prevent Infection
11/06/2024
MHSRS is America’s Foremost Annual Military Healthcare Conference PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Origin Life Sciences, Inc., a clinical-stage biotechnology company developing a proprietary patented [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 23 - 2024
11/06/2024
Aggregated presentation by day and by market Statement of transactions in own shares from June 3 to June 7, 2024 Name of issuer Identification code of issuer (Legal Entity Identifier) Day of transaction Identification [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 23 - 2024
11/06/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 3 au 7 juin 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
11/06/2024
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic [...]
Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National Capital
11/06/2024
MCLEAN, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, is the winner of [...]
AI Brain Health Leader Omniscient Closes Series C Funding Round
11/06/2024
Omniscient’s revolutionary platform, Quicktome®, leverages AI to convert a standard MRI scan into a detailed map of an individual’s brain networks. The latest funding round will support continued growth in the US market [...]
Racial Disparities in HIV Testing Require Explanation, according to Journal of American Physicians and Surgeons
11/06/2024
TUCSON, Ariz., June 11, 2024 (GLOBE NEWSWIRE) -- People of African ancestry test positive for the human immunodeficiency virus (HIV) much more often than people of other racial groups, writes Henry H. Bauer , Ph.D., in [...]
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy with an Aim to Expedite BLA Pathway
11/06/2024
--FDA Grants Pre-BLA Meeting Request and Rolling BLA Submission after Review of HOPE-2 and HOPE-2 OLE 3-Year Results-- SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology [...]
Outlook Therapeutics® to Present at the Virtual Investor Pitch Conference
11/06/2024
Live video webcast on Tuesday, June 18 th at 12:00 PM ET ISELIN, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the commercialization and [...]

Pages